Showing results (381-390 of 604) with videos related to
Sort By:
Pageof 61
Molecular Cancer|December 31, 2013
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathwayLu Qian Wang, Yok Lam Kwong, Chi Shan Bonnie Kho, et al.Oncogene|May 10, 2016
Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5S Wang, Y Pan, R Zhang, et al.Blood|May 24, 2011
Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndromeZhuang Zuo, George A Calin, Henrique M de Paula, et al.Journal of Cellular and Molecular Medicine|September 10, 2019
The non-coding RNome after splenectomyMihnea P Dragomir, Stefan Tudor, Keishi Okubo, et al.Cancer Research|November 19, 2004
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancerElena Miotto, Silvia Sabbioni, Angelo Veronese, et al.Oncotarget|September 13, 2015
Progresses towards safe and efficient gene therapy vectorsSergiu Chira, Carlo S Jackson, Iulian Oprea, et al.Haematologica|July 7, 2018
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathwaysLynne V Abruzzo, Carmen D Herling, George A Calin, et al.Cancer Research|August 3, 2005
Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiencyNicola Zanesi, Rita Mancini, Cinzia Sevignani, et al.Oncogene|June 4, 2008
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaF Fornari, L Gramantieri, M Ferracin, et al.Nucleic Acids Research|July 27, 2014
The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associationsYuanbin Ru, Katerina J Kechris, Boris Tabakoff, et al.Pageof 61